CD40 Antikörper (Extracellular Domain)
Kurzübersicht für CD40 Antikörper (Extracellular Domain) (ABIN6976359)
Target
Alle CD40 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
- 
    
- 
                                            
Bindungsspezifität
 - Extracellular Domain
 - 
                                            
Aufreinigung
 - affinity purified
 - 
                                            
Reinheit
 - > 95 %
 - 
                                            
Immunogen
 - Purified recombinant extracellular domain of human CD-40
 - 
                                            
Isotyp
 - IgG1
 
 - 
                                            
 - 
    
 - 
    
- 
                                            
Applikationshinweise
 - Optimal working dilution should be determined by the investigator.
 - 
                                            
Kommentare
 - 
                        
Works in sandwich ELISA with 16B4E4 (ABIN6976360)
 - 
                                            
Beschränkungen
 - Nur für Forschungszwecke einsetzbar
 
 - 
                                            
 - 
    
- 
                                            
Format
 - Liquid
 - 
                                            
Konzentration
 - 0.5 mg/mL
 - 
                                            
Buffer
 - PBS
 - 
                                            
Lagerung
 - 4 °C,-20 °C
 - 
                                            
Informationen zur Lagerung
 - Store at 4 °C, short term (1-2 weeks). For long-term storage, aliquot and keep at or below -20° C. Avoid repeated freeze-thaw cycles
 
 - 
                                            
 - 
    
- CD40
 - 
                                            
Andere Bezeichnung
 - CD-40
 - 
                                            
Hintergrund
 - Mouse anti-CD-40, sandwich ELISA with 16B4E4
 - 
                                            
Pathways
 - NF-kappaB Signalweg, Cellular Response to Molecule of Bacterial Origin, M Phase, Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Production of Molecular Mediator of Immune Response, Cancer Immune Checkpoints
 
Target
 -